ID   UBP25_HUMAN             Reviewed;        1055 AA.
AC   Q9UHP3; C0LSZ0; Q6DHZ9; Q9H9W1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 4.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 25;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 25;
DE   AltName: Full=USP on chromosome 21;
DE   AltName: Full=Ubiquitin thioesterase 25;
DE   AltName: Full=Ubiquitin-specific-processing protease 25;
GN   Name=USP25; Synonyms=USP21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS USP25A AND USP25B), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=10644437; DOI=10.1006/geno.1999.6025;
RA   Valero R., Marfany G., Gonzalez-Angulo O., Gonzalez-Gonzalez G.,
RA   Puelles L., Gonzalez-Duarte R.;
RT   "USP25, a novel gene encoding a deubiquitinating enzyme, is located in
RT   the gene-poor region 21q11.2.";
RL   Genomics 62:395-405(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM USP25A), AND FUNCTION.
RX   PubMed=10612803;
RX   DOI=10.1002/(SICI)1098-2264(200002)27:2<153::AID-GCC6>3.0.CO;2-A;
RA   Groet J., Ives J.H., Jones T.A., Danton M., Flomen R.H., Sheer D.,
RA   Hrascan R., Pavelic K., Nizetic D.;
RT   "Narrowing of the region of allelic loss in 21q11-21 in squamous non-
RT   small cell lung carcinoma and cloning of a novel ubiquitin-specific
RT   protease gene from the deleted segment.";
RL   Genes Chromosomes Cancer 27:153-161(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM USP25M).
RA   Valero R., Bosch-Comas A., Denuc A., Gonzalez-Duarte R., Marfany G.;
RL   Submitted (FEB-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM USP25A).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 319-1055 (ISOFORM USP25A).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   ALTERNATIVE SPLICING, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11597335; DOI=10.1186/gb-2001-2-10-research0043;
RA   Valero R., Bayes M., Francisca Sanchez-Font M., Gonzalez-Angulo O.,
RA   Gonzalez-Duarte R., Marfany G.;
RT   "Characterization of alternatively spliced products and tissue-
RT   specific isoforms of USP28 and USP25.";
RL   Genome Biol. 2:RESEARCH0043.1-RESEARCH0043.10(2001).
RN   [8]
RP   ALTERNATIVE SPLICING, INTERACTION WITH ACTA1; FLNC; GAPDH AND MYBPC1,
RP   INDUCTION, SUBCELLULAR LOCATION, AND POSSIBLE FUNCTION.
RX   PubMed=16501887; DOI=10.1007/s00018-005-5533-1;
RA   Bosch-Comas A., Lindsten K., Gonzalez-Duarte R., Masucci M.G.,
RA   Marfany G.;
RT   "The ubiquitin-specific protease USP25 interacts with three sarcomeric
RT   proteins.";
RL   Cell. Mol. Life Sci. 63:723-734(2006).
RN   [9]
RP   SUMOYLATION AT LYS-99, FUNCTION, INTERACTION WITH SUMO1; SUMO3 AND
RP   UBIQUITIN, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   VAL-91; ILE-92 AND LYS-99.
RX   PubMed=18538659; DOI=10.1016/j.molcel.2008.03.021;
RA   Meulmeester E., Kunze M., Hsiao H.H., Urlaub H., Melchior F.;
RT   "Mechanism and consequences for paralog-specific sumoylation of
RT   ubiquitin-specific protease 25.";
RL   Mol. Cell 30:610-619(2008).
RN   [10]
RP   UBIQUITINATION AT LYS-99, DEUBIQUITINATION, ACTIVE SITE CYS-178,
RP   ACETYLATION, PHOSPHORYLATION, SUMOYLATION, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, AND MUTAGENESIS OF LYS-99 AND CYS-178.
RX   PubMed=19440361; DOI=10.1371/journal.pone.0005571;
RA   Denuc A., Bosch-Comas A., Gonzalez-Duarte R., Marfany G.;
RT   "The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination
RT   state and modulate substrate recognition.";
RL   PLoS ONE 4:E5571-E5571(2009).
RN   [11]
RP   INTERACTION WITH SYK, PHOSPHORYLATION AT TYR-740, AND MUTAGENESIS OF
RP   TYR-740; THR-878; TYR-880 AND ILE-883.
RX   PubMed=19909739; DOI=10.1016/j.yexcr.2009.10.023;
RA   Cholay M., Reverdy C., Benarous R., Colland F., Daviet L.;
RT   "Functional interaction between the ubiquitin-specific protease 25 and
RT   the SYK tyrosine kinase.";
RL   Exp. Cell Res. 316:667-675(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Deubiquitinating enzyme that hydrolyzes ubiquitin
CC       moieties conjugated to substrates and thus, functions to process
CC       newly synthesized Ubiquitin, to recycle ubiquitin molecules or to
CC       edit polyubiquitin chains and prevents proteasomal degradation of
CC       substrates. Hydrolyzes both 'Lys-48'- and 'Lys-63'-linked
CC       tetraubiquitin chains.
CC   -!- FUNCTION: The muscle-specific isoform (USP25m) may have a role in
CC       the regulation of muscular differentiation and function.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Homodimer or oligomer. Interacts with ACTA1 (via its C-
CC       terminus); the interaction occurs for all isoforms but is
CC       strongest for isoform USP25m in muscle differentiating cells.
CC       Interacts (isoform USP25m only) with MYBPC1; the interaction
CC       prevents proteasomal degradation of MYBPC1. Interacts (isoform
CC       USP25m only) with FLNC (via filament repeats 17-18, 20-21 and 24).
CC       Interacts with GAPDH. Interacts with SUMO3; the interaction
CC       sumoylates efficiently USP25. Interacts with SUMO2; the
CC       interaction sumoylates efficiently USP25. Interacts with SUMO1;
CC       the interaction only weakly sumoylates USP25. Interacts with SYK;
CC       phosphorylates USP25 and regulates USP25 intracellular levels.
CC       {ECO:0000269|PubMed:16501887, ECO:0000269|PubMed:18538659,
CC       ECO:0000269|PubMed:19440361, ECO:0000269|PubMed:19909739}.
CC   -!- INTERACTION:
CC       O15481:MAGEB4; NbExp=3; IntAct=EBI-2513462, EBI-751857;
CC       P54725:RAD23A; NbExp=7; IntAct=EBI-2513462, EBI-746453;
CC       P61956:SUMO2; NbExp=5; IntAct=EBI-2513462, EBI-473220;
CC       P43405:SYK; NbExp=6; IntAct=EBI-2513462, EBI-78302;
CC       Q9BUY5:ZNF426; NbExp=3; IntAct=EBI-2513462, EBI-743265;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16501887,
CC       ECO:0000269|PubMed:19440361}.
CC   -!- SUBCELLULAR LOCATION: Isoform USP25m: Cytoplasm {ECO:0000250}.
CC       Nucleus {ECO:0000250}. Note=Some transient punctuate nuclear
CC       location in myotubes during myocyte development. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=USP25a;
CC         IsoId=Q9UHP3-2; Sequence=Displayed;
CC       Name=USP25b;
CC         IsoId=Q9UHP3-1; Sequence=VSP_039632;
CC       Name=USP25m; Synonyms=Muscle-specific isoform;
CC         IsoId=Q9UHP3-3; Sequence=VSP_039631;
CC   -!- TISSUE SPECIFICITY: Isoform USP25a is found in most adult and
CC       fetal tissues; expression is moderately high in testis, pancreas,
CC       kidney, skeletal muscle, liver, lung, placenta, brain, heart, but
CC       very low in peripheral blood, colon, small intestine, ovary,
CC       prostate, thymus and spleen. Isoform USP25b is found in all
CC       tissues except heart and skeletal muscle. Isoform USP25m is heart
CC       and skeletal muscle specific. {ECO:0000269|PubMed:10644437,
CC       ECO:0000269|PubMed:11597335}.
CC   -!- INDUCTION: The muscle-specific isoform (USP25m) is up-regulated
CC       during myocyte differentiation. Levels increase up to 100-fold
CC       towards completion of differentiation.
CC       {ECO:0000269|PubMed:16501887}.
CC   -!- PTM: Acetylated. {ECO:0000269|PubMed:19440361}.
CC   -!- PTM: Sumoylation impairs binding to and hydrolysis of ubiquitin
CC       chains. Sumoylated preferentially with SUMO2 or SUMO3.
CC       Desumoylated by SENP1. Regulated by ubiquitination on the same
CC       residue. {ECO:0000269|PubMed:19440361}.
CC   -!- PTM: Preferentially monoubiquitinated but can also be
CC       polyubiquitinated. Autodeubiquitinated. Ubiquitination activates
CC       the enzymatic activity either by preventing sumoylation or by
CC       allowing novel interactions. {ECO:0000269|PubMed:19440361}.
CC   -!- PTM: Phosphorylation in the C-terminal by SYK regulates USP25
CC       cellular levels. {ECO:0000269|PubMed:19440361,
CC       ECO:0000269|PubMed:19909739}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF170562; AAF32263.1; -; mRNA.
DR   EMBL; AF134213; AAF24998.1; -; mRNA.
DR   EMBL; FJ763652; ACN76567.1; -; mRNA.
DR   EMBL; CH471079; EAX10041.1; -; Genomic_DNA.
DR   EMBL; BC075792; AAH75792.1; -; mRNA.
DR   EMBL; AK022574; BAB14107.1; -; mRNA.
DR   CCDS; CCDS33515.1; -. [Q9UHP3-2]
DR   CCDS; CCDS63336.1; -. [Q9UHP3-3]
DR   CCDS; CCDS63337.1; -. [Q9UHP3-1]
DR   RefSeq; NP_001269970.1; NM_001283041.1. [Q9UHP3-3]
DR   RefSeq; NP_001269971.1; NM_001283042.1. [Q9UHP3-1]
DR   RefSeq; NP_037528.3; NM_013396.4. [Q9UHP3-2]
DR   UniGene; Hs.743994; -.
DR   PDB; 2MUX; NMR; -; A=1-146.
DR   PDBsum; 2MUX; -.
DR   ProteinModelPortal; Q9UHP3; -.
DR   SMR; Q9UHP3; -.
DR   BioGrid; 118895; 45.
DR   IntAct; Q9UHP3; 26.
DR   MINT; MINT-1188384; -.
DR   STRING; 9606.ENSP00000285679; -.
DR   MEROPS; C19.041; -.
DR   iPTMnet; Q9UHP3; -.
DR   PhosphoSitePlus; Q9UHP3; -.
DR   DMDM; 302393833; -.
DR   EPD; Q9UHP3; -.
DR   MaxQB; Q9UHP3; -.
DR   PaxDb; Q9UHP3; -.
DR   PeptideAtlas; Q9UHP3; -.
DR   PRIDE; Q9UHP3; -.
DR   DNASU; 29761; -.
DR   Ensembl; ENST00000285679; ENSP00000285679; ENSG00000155313. [Q9UHP3-2]
DR   Ensembl; ENST00000285681; ENSP00000285681; ENSG00000155313. [Q9UHP3-1]
DR   Ensembl; ENST00000400183; ENSP00000383044; ENSG00000155313. [Q9UHP3-3]
DR   GeneID; 29761; -.
DR   KEGG; hsa:29761; -.
DR   UCSC; uc002yjy.3; human. [Q9UHP3-2]
DR   CTD; 29761; -.
DR   DisGeNET; 29761; -.
DR   GeneCards; USP25; -.
DR   HGNC; HGNC:12624; USP25.
DR   HPA; HPA018297; -.
DR   HPA; HPA024142; -.
DR   MIM; 604736; gene.
DR   neXtProt; NX_Q9UHP3; -.
DR   OpenTargets; ENSG00000155313; -.
DR   PharmGKB; PA37249; -.
DR   eggNOG; KOG1863; Eukaryota.
DR   eggNOG; COG5077; LUCA.
DR   GeneTree; ENSGT00390000016082; -.
DR   HOGENOM; HOG000007956; -.
DR   HOVERGEN; HBG056030; -.
DR   InParanoid; Q9UHP3; -.
DR   KO; K11849; -.
DR   OMA; NMQGIIM; -.
DR   OrthoDB; EOG091G00QR; -.
DR   PhylomeDB; Q9UHP3; -.
DR   TreeFam; TF329035; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP25; human.
DR   GenomeRNAi; 29761; -.
DR   PRO; PR:Q9UHP3; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000155313; -.
DR   CleanEx; HS_USP21; -.
DR   CleanEx; HS_USP25; -.
DR   ExpressionAtlas; Q9UHP3; baseline and differential.
DR   Genevisible; Q9UHP3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0051117; F:ATPase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0008233; F:peptidase activity; TAS:ProtInc.
DR   GO; GO:0032183; F:SUMO binding; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IMP:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0043130; F:ubiquitin binding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1904455; F:ubiquitin-specific protease activity involved in negative regulation of ERAD pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:1904293; P:negative regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR009060; UBA-like.
DR   InterPro; IPR003903; UIM_dom.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02809; UIM; 2.
DR   SMART; SM00726; UIM; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   PROSITE; PS50330; UIM; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Hydrolase; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Protease; Reference proteome; Repeat; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   1055       Ubiquitin carboxyl-terminal hydrolase 25.
FT                                /FTId=PRO_0000080653.
FT   DOMAIN       14     57       UBA-like.
FT   DOMAIN       97    116       UIM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   DOMAIN      123    140       UIM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   DOMAIN      169    657       USP.
FT   REGION       77    102       SUMO interaction domain (SIM).
FT   COILED      541    578       {ECO:0000255}.
FT   COILED      684    717       {ECO:0000255}.
FT   MOTIF        89     95       Required for SUMO paralog-specific
FT                                binding.
FT   ACT_SITE    178    178       {ECO:0000269|PubMed:19440361}.
FT   ACT_SITE    599    599       {ECO:0000250}.
FT   ACT_SITE    607    607       {ECO:0000250}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     740    740       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:19909739}.
FT   CROSSLNK     99     99       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK     99     99       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:19440361}.
FT   VAR_SEQ     779    779       S -> SIMMTPNMQGIIMAIGKSRSVYDRCGPEAGFFK
FT                                (in isoform USP25b).
FT                                {ECO:0000303|PubMed:10644437}.
FT                                /FTId=VSP_039632.
FT   VAR_SEQ     779    779       S -> SKPENTTSQPLSNQRVVEVAIPHVGKFMIESKEGGY
FT                                DDEIMMTPNMQGIIMAIGKSRSVYDRCGPEAGFFK (in
FT                                isoform USP25m). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_039631.
FT   MUTAGEN      91     91       V->A: No interaction with SUMO3; when
FT                                associated with A-92.
FT                                {ECO:0000269|PubMed:18538659}.
FT   MUTAGEN      92     92       I->A: No interaction with SUMO3; when
FT                                associated with A-91.
FT                                {ECO:0000269|PubMed:18538659}.
FT   MUTAGEN      99     99       K->R: Abolishes sumoylation. Decreased
FT                                enzymatic activity.
FT                                {ECO:0000269|PubMed:18538659,
FT                                ECO:0000269|PubMed:19440361}.
FT   MUTAGEN     178    178       C->S: Abrogates deubiquitinating
FT                                activity. No effect on homo- or
FT                                oligomerization.
FT                                {ECO:0000269|PubMed:19440361}.
FT   MUTAGEN     740    740       Y->F: No effect on interaction with SYK.
FT                                {ECO:0000269|PubMed:19909739}.
FT   MUTAGEN     878    878       T->I: No effect on interaction with SYK.
FT                                {ECO:0000269|PubMed:19909739}.
FT   MUTAGEN     880    880       Y->F: No effect on interaction with SYK.
FT                                {ECO:0000269|PubMed:19909739}.
FT   MUTAGEN     883    883       I->S: No effect on interaction with SYK.
FT                                {ECO:0000269|PubMed:19909739}.
FT   CONFLICT    544    544       E -> K (in Ref. 1; AAF32263 and 3;
FT                                ACN76567). {ECO:0000305}.
FT   HELIX        12     27       {ECO:0000244|PDB:2MUX}.
FT   HELIX        33     43       {ECO:0000244|PDB:2MUX}.
FT   HELIX        47     55       {ECO:0000244|PDB:2MUX}.
FT   STRAND       61     64       {ECO:0000244|PDB:2MUX}.
FT   STRAND       69     71       {ECO:0000244|PDB:2MUX}.
FT   HELIX       100    116       {ECO:0000244|PDB:2MUX}.
FT   HELIX       125    136       {ECO:0000244|PDB:2MUX}.
SQ   SEQUENCE   1055 AA;  122218 MW;  0B9CECDCAD619CF2 CRC64;
     MTVEQNVLQQ SAAQKHQQTF LNQLREITGI NDTQILQQAL KDSNGNLELA VAFLTAKNAK
     TPQQEETTYY QTALPGNDRY ISVGSQADTN VIDLTGDDKD DLQRAIALSL AESNRAFRET
     GITDEEQAIS RVLEASIAEN KACLKRTPTE VWRDSRNPYD RKRQDKAPVG LKNVGNTCWF
     SAVIQSLFNL LEFRRLVLNY KPPSNAQDLP RNQKEHRNLP FMRELRYLFA LLVGTKRKYV
     DPSRAVEILK DAFKSNDSQQ QDVSEFTHKL LDWLEDAFQM KAEEETDEEK PKNPMVELFY
     GRFLAVGVLE GKKFENTEMF GQYPLQVNGF KDLHECLEAA MIEGEIESLH SENSGKSGQE
     HWFTELPPVL TFELSRFEFN QALGRPEKIH NKLEFPQVLY LDRYMHRNRE ITRIKREEIK
     RLKDYLTVLQ QRLERYLSYG SGPKRFPLVD VLQYALEFAS SKPVCTSPVD DIDASSPPSG
     SIPSQTLPST TEQQGALSSE LPSTSPSSVA AISSRSVIHK PFTQSRIPPD LPMHPAPRHI
     TEEELSVLES CLHRWRTEIE NDTRDLQESI SRIHRTIELM YSDKSMIQVP YRLHAVLVHE
     GQANAGHYWA YIFDHRESRW MKYNDIAVTK SSWEELVRDS FGGYRNASAY CLMYINDKAQ
     FLIQEEFNKE TGQPLVGIET LPPDLRDFVE EDNQRFEKEL EEWDAQLAQK ALQEKLLASQ
     KLRESETSVT TAQAAGDPEY LEQPSRSDFS KHLKEETIQI ITKASHEHED KSPETVLQSA
     IKLEYARLVK LAQEDTPPET DYRLHHVVVY FIQNQAPKKI IEKTLLEQFG DRNLSFDERC
     HNIMKVAQAK LEMIKPEEVN LEEYEEWHQD YRKFRETTMY LIIGLENFQR ESYIDSLLFL
     ICAYQNNKEL LSKGLYRGHD EELISHYRRE CLLKLNEQAA ELFESGEDRE VNNGLIIMNE
     FIVPFLPLLL VDEMEEKDIL AVEDMRNRWC SYLGQEMEPH LQEKLTDFLP KLLDCSMEIK
     SFHEPPKLPS YSTHELCERF ARIMLSLSRT PADGR
//
